As Sernova Corp prepares to release its next earnings report, investors are eager to see if the biotechnology firm can finally break its streak of misses.
Sernova Corp (SVA.TO), a player in the health care biotechnology sector, is set to announce its earnings for the fiscal period ending July 31, 2026, on September 10, 2026, after market hours. With an EPS estimate of -$0.01, the company has not surpassed this mark in its last four quarters, leading to heightened anticipation among investors.
Recent earnings trend
Advertisement
Sernova Corp
SVA.TO
SVA.TO
Sernova Corp
WealthAwesomeMarket cap
$41.54M
52W high
$0.20
52W low
$0.10
1W change
+0.00%
Beta
0.64
Analyst Price Targets
Based on analyst covering SVA
Wall Street analysts forecast SVA stock price to rise 309.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.45
+309.1% Upside
Current Price
C$0.11
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SVA's historical volatility
30-Day Vol
61.9%
Annualized
90-Day Vol
81.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.10 | C$0.08 โ C$0.13 |
| 60 trading days | C$0.10 | C$0.07 โ C$0.13 |
| 90 trading days | C$0.09 | C$0.06 โ C$0.13 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-07-31 | 2026-09-10 | โ | -0.0100 | โ |
| 2026-04-30 | 2026-06-11 | -0.0100 | -0.0100 | +0.0% |
| 2026-01-31 | 2026-03-13 | -0.0100 | -0.0100 | +0.0% |
| 2025-10-31 | 2025-12-19 | -0.0100 | -0.0100 | +0.0% |
| 2025-07-31 | 2025-09-15 | -0.0100 | -0.0100 | +0.0% |
| 2025-04-30 | 2025-06-13 | -0.0100 | -0.0200 | +50.0% |
Advertisement
Investor takeaway: With a history of meeting EPS estimates but never beating them, Sernova's upcoming report will be crucial for investor sentiment. The companyโs ability to maintain its market cap and attract further investments depends on its performance in this earnings cycle.
EPS Estimate Stands at -$0.01
Sernova's EPS estimate shows stagnation, with no growth projected compared to the same period last year.
Bull case
If Sernova can report an EPS that matches the estimate, it may indicate stability and the potential for future growth. This is particularly relevant given its recent financing activities and FDA Orphan Drug Designation.
Bear case
On the other hand, failing to meet even these low expectations could further undermine investor confidence, especially since the company has not shown any growth in revenue or EPS over the past year.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
